Sarcopenia prevalence and functional outcomes in older men with obesity: Comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitions

• DOI: 10.1016/j.clnu.2023.07.014
• Publication Date: 2023-07-18T00:30:53Z
• Authors: David Scott; Fiona Blyth; Vasi Naganathan; David G. Le Couteur; David J. Handelsman; Louise M. Waite; Vasant Hirani
• Keywords: Sarcopenic obesity

The potential for older adults with obesity to also have sarcopenia, and the health consequences of 'sarcopenic obesity', may be underappreciated by professionals. primary aim this secondary analysis a prospective cohort study men was explore prevalence functional outcomes sarcopenic based on different consensus definitions.1416 community-dwelling aged ≥70 years were classified into sarcopenia categories according European Working Group Sarcopenia in Older People (EWGSOP2) definition, Society Clinical Nutrition Metabolism Association Study Obesity (ESPEN-EASO) definition. Descriptive analyses determined obese non-obese men. Multivariable compared associations including activity daily living (ADL) instrumental (IADL) disability 12-month incident falls.According EWGSOP2 12.6% had confirmed but only 0.3% (BMI ≥30 kg/m2). Conversely, 9.6% ESPEN-EASO Notably, no BMI ≥32 kg/m2 as having EWGSOP2-confirmed despite fact that 60.8% all low muscle strength. Due numbers (N = 4) not assessed. Men definition significantly lower hand grip strength, higher chair-stands time slower gait speed (all P < 0.05), increased odds ADL (odds ratio: 5.02, 95% CI: 1.85-13.58) IADL (2.18, 1.38-3.45) disability, falls rates (incident rate 1.59, 1.03-2.44) than neither nor obesity.Low strength is common obesity, likely underestimated when operational applied population. appears provide valid approach identifying who are at risk poor related sarcopenia.